Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thyroid Diseases × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 42 Carcinoma, Hepatocellular 39 Carcinoma, Non-Small-Cell Lung 15 Colorectal Neoplasms 12 Small Cell Lung Carcinoma 11 Ovarian Neoplasms 11 Nasopharyngeal Carcinoma 11 Breast Neoplasms 11 Sarcoma 10 Cholangiocarcinoma 10 Triple Negative Breast Neoplasms 9 Lung Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Esophageal Neoplasms 9 Osteosarcoma 7 Advanced Gastric Cancer 7 Neoplasms 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Recurrence 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Liver Neoplasms 5 Uterine Cervical Neoplasms 4 Glioma 4 Thyroid Neoplasms 3 Melanoma 3 Gastrointestinal Neoplasms 3 Drug-Related Side Effects and Adverse Reactions 3

Interventions

Sorafenib 3 cabozantinib 2 Sodium 2 Radiofrequency Ablation 2 Metformin 2 Data Collection 2 vandetanib 1 temsirolimus 1 pembrolizumab 1 lenvatinib 1 apatinib 1 acetaminophen, codeine drug combination 1 Watchful Waiting 1 Tramadol 1 Thyroxine 1 Thyroidectomy 1 Thyroid (USP) 1 Technetium Tc 99m Sestamibi 1 Panobinostat 1 Negative-Pressure Wound Therapy 1 NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1 Lysine Acetyltransferase 5 1 Iodine-131 1 Interviews as Topic 1 Hyperspectral Imaging 1 Focus Groups 1 Fluorescein 1 Everolimus 1 Drug Therapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04180007 2019-11-27

APT-01

Nanjing First Hospital, Nanjing Medical University

Phase 2 Unknown

Neoplasm Metastasis, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡